LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

A Non-Invasive Skin Test Accurately Diagnoses Covid-19

By LabMedica International staff writers
Posted on 21 Jul 2022
Image: Test tube with swab for coronavirus analysis (Photo courtesy of 123rf.com)
Image: Test tube with swab for coronavirus analysis (Photo courtesy of 123rf.com)

Metabolic changes caused by Covid-19 infection can be detected in skin and saliva samples as well as in the blood, which suggest that noninvasive diagnostic tests for the disease could be available in the near future.

Investigators at the University of Surrey (United Kingdom) analyzed the correlations between serum metabolites, salivary metabolites, and skin sebum lipids in Covid-19 positive and negative individuals. In this study, 83 Covid-19 positive and negative hospitalized participants provided blood serum alongside saliva and sebum samples for analysis by liquid chromatography mass spectrometry. Participants were requested to provide all three biofluids, but due to declined consent for blood sampling, or inability to express saliva or easily provide blood, not all participants provided all three biofluids. All samples (sebum, saliva, and serum) were taken from each patient within 20 minutes of one another.

Results revealed widespread alterations to serum-sebum lipid relationships in Covid-19 positive participants versus negative controls. There was also a marked correlation between sebum lipids and the immunostimulatory hormone dehydroepiandrosterone sulfate in the Covid-19 positive group.

The biofluids were also compared in terms of their ability to differentiate COVID-19 positive participants from controls. Thus, serum performed best by multivariate analysis (sensitivity and specificity of 0.97), with the dominant changes in triglyceride and bile acid levels, in agreement with other studies identifying dyslipidemia as a hallmark of Covid-19 infection. Sebum performed well (sensitivity 0.92; specificity 0.84), with saliva performing worst (sensitivity 0.78; specificity 0.83). These findings confirmed that alterations to skin lipid profiles coincided with dyslipidaemia in serum.

Senior author Dr. Melanie Bailey, reader in analytical science the University of Surrey, said, "Covid-19 has shown us that rapid testing is vital in monitoring and identifying new illnesses. In our research, we explored the relationships between different biofluids, and what changes in one part of the human body can tell us about the overall health of a patient. Our results show that, while blood is the most accurate way of testing for this virus, skin swabs are not too far behind - in fact, the skin swab results were surprisingly accurate."

The study was published in the July 13, 2022, online edition of the journal Scientific Reports.

Related Links:
University of Surrey 

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more